Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

The need for greater opioid pharmacovigilance in COPD

Authors Vozoris NT

Received 22 November 2016

Accepted for publication 28 November 2016

Published 6 January 2017 Volume 2017:12 Pages 189—192

DOI https://doi.org/10.2147/COPD.S128441

Checked for plagiarism Yes

Editor who approved publication: Dr Richard Russell

Nicholas T Vozoris1–3

1Division of Respirology, Department of Medicine, St Michael’s Hospital, Toronto, ON, Canada; 2Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, ON, Canada; 3Department of Medicine, University of Toronto, Toronto, ON, Canada
 
I read with interest the article by Ahmadi et al1 that described the use of prescription opioid drugs among Swedes with advanced COPD. The authors are to be commended for their research work on this important clinical topic. I would like to bring to the attention of your readers several points though. 
Read the original article by Ahmadi et al

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]